Navigation Links
Anacor Raises $50 Million in Equity Financing
Date:1/6/2009

PALO ALTO, Calif., Jan. 6 /PRNewswire/ -- Anacor Pharmaceuticals today announced that it has raised $50 million through a preferred stock financing with participation from GlaxoSmithKline, Schering Corporation and existing investors including Rho Capital Partners, Venrock Associates, Care Capital and Aberdare Ventures. Proceeds from the financing will be used to further develop Anacor's product pipeline based on its boron chemistry platform.

"We are pleased to complete this financing, which will allow us to advance our five clinical programs and to identify and progress new compounds derived from our boron chemistry platform," said David Perry, Chief Executive Officer at Anacor Pharmaceuticals.

The investments from GSK and Schering Corporation fulfill each company's investment obligations pursuant to their respective and ongoing collaborations with Anacor. At the conclusion of the financing, the combined ownership of GSK and Schering Corporation will be less than 20 percent of Anacor's outstanding shares.

About Anacor Pharmaceuticals

Anacor is a biopharmaceutical company developing novel small molecule therapeutics derived from its boron chemistry platform. Anacor has focused initially on developing topical applications of its compounds to treat fungal, bacterial and inflammatory diseases. Anacor's most advanced product candidate is AN2690, a novel topical antifungal in development for the treatment of toenail onychomycosis, which is a fungal infection of the nail and nail bed. AN2690 is licensed to Schering under a worldwide development and commercialization agreement for all indications including the treatment of onychomycosis. Anacor also has a research and development collaboration with GlaxoSmithKline for the discovery, development, manufacture and worldwide commercialization of novel systemic therapeutics for viral and bacterial diseases utilizing Anacor's boron-based
'/>"/>

SOURCE Anacor Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Anacor Pharmaceuticals Appoints Dr. Kurt Jarnagin Vice President of Biological Research
2. Anacor to Present Clinical and Preclinical Data on Topical Anti-Inflammatory Candidates, AN2728 and AN2898, at the International Investigative Dermatology 2008 Conference
3. GlaxoSmithKline and Anacor Pharmaceuticals Form Alliance to Develop Systemic Antivirals and Antibiotics Based on Boron Chemistry
4. Anacor Files Registration Statement for Initial Public Offering
5. MichBio Expo Draws Nearly 500 Professionals; Career Day Raises Profile
6. Sensorin Raises Equity Financing to Launch Novel Industrial Sensing Venture
7. Simbionix Raises Largest Amount in Companys History in Venture Capital to Accelerate Growth
8. Vista Partners Updates Coverage on Arana Therapeutics (ASX: AAH; AIM: AAHx), Raises Target Price to AU$1.65
9. Ameristar National Charity Golf Classic Raises More Than $1.1 Million for Buoniconti Fund to Cure Paralysis and Christopher & Dana Reeve Foundation
10. China Sky One Medical, Inc. Raises Guidance for 2008 Revenue and Net Income
11. MacroGenics Raises $25M in Series D-2 Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2012)... May 21, 2012 Genesis Biopharma, Inc. ... immunotherapies, announces the posting of the following Letter ... Company,s website at www.genesis-biopharma.com .  In addition, ... the U.S. Securities and Exchange Commission its Quarterly ... 2012 on Form 10-Q.  The Form 10-Q includes ...
(Date:5/18/2012)... DIEGO, May 18, 2012 Sequenom, Inc. (NASDAQ: ... innovative genetic analysis solutions, today announced that a new ... study on the Sequenom Center for Molecular Medicine,s (Sequenom ... been published online in the peer-reviewed journal, Prenatal ... announces that as of the week ended May 12, ...
(Date:5/16/2012)... 2011, nearly fifteen years after she became paralyzed and ... by thinking about moving her arm and hand to ... take a drink. That achievement is one of the ... technology described in the May 17 edition of the ... researchers at the Department of Veterans Affairs, Brown University, ...
(Date:5/16/2012)... ANAHEIM, Calif., May 16, 2012  Questcor Pharmaceuticals, ... that its Board of Directors has increased the ... additional 5 million shares. Since the ... million to shareholders through the repurchase of approximately ... 27% of its shares as of the commencement ...
Breaking Biology Technology:Genesis Biopharma Issues Letter To Shareholders 2Genesis Biopharma Issues Letter To Shareholders 3Genesis Biopharma Issues Letter To Shareholders 4Study In Prenatal Diagnosis Finds Sequenom CMM's MaterniT21™ PLUS Lab-developed Test Accurately Detects Fetal Trisomies In Pregnant Women Carrying Twins Or Triplets 2Study In Prenatal Diagnosis Finds Sequenom CMM's MaterniT21™ PLUS Lab-developed Test Accurately Detects Fetal Trisomies In Pregnant Women Carrying Twins Or Triplets 3Study In Prenatal Diagnosis Finds Sequenom CMM's MaterniT21™ PLUS Lab-developed Test Accurately Detects Fetal Trisomies In Pregnant Women Carrying Twins Or Triplets 4Study In Prenatal Diagnosis Finds Sequenom CMM's MaterniT21™ PLUS Lab-developed Test Accurately Detects Fetal Trisomies In Pregnant Women Carrying Twins Or Triplets 5People with paralysis control robotic arms to reach and grasp using brain computer interface 2People with paralysis control robotic arms to reach and grasp using brain computer interface 3People with paralysis control robotic arms to reach and grasp using brain computer interface 4People with paralysis control robotic arms to reach and grasp using brain computer interface 5Questcor Pharmaceuticals Expands Repurchase Program 2Questcor Pharmaceuticals Expands Repurchase Program 3Questcor Pharmaceuticals Expands Repurchase Program 4Questcor Pharmaceuticals Expands Repurchase Program 5
... as I sat at lunch sending off a series of ... how our professional lives continue to evolve dramatically, and in ... of a company that is driving the adoption of Internet ... quickly technological change continues to transform and enhance our professional ...
... Worst Phone UI Ever, in which I vented my ... Since that column, most people running start ups to develop mobile ... come to tell be about their products. Remarkably, most of these ... well-resourced Cingular and its OEM partner, HTC . ...
... - Norlight Telecommunications, Inc., which will spin ... it will roll out its new Voice over Internet ... Green Bay and Madison. , ,The facilities-based communications ... by offering integrated communications bundles of local voice, long ...
Other Biology Technology:Visions: Rimas Buinevicius, CEO of Sonic Foundry 2Visions: Rimas Buinevicius, CEO of Sonic Foundry 3More women needed in interface design 2More women needed in interface design 3More women needed in interface design 4Norlight will offer VoIP in Madison, Green Bay 2
(Date:5/21/2012)... by financial strategists to determine what shares to purchase ... develop a diversified portfolio of another kind -- land ... uncertainty about climate change. , Instead of plugging into ... stock, University of Illinois environmental economist Amy Ando and ... of the Prairie Pothole Region of the northern Great ...
(Date:5/21/2012)... . ,, Castor oil is known primarily as ... times with pregnant women to induce labour. Only now have ... Research succeeded in unravelling the mysteries of the action mechanism. ... of the intestine and uterus is apparently responsible. This is ... obtained from the seeds of the castor oil plant ...
(Date:5/21/2012)... Ind. - Researchers at Purdue University are working with ... Reed National Military Medical Center to create a new ... brain aneurisms including those caused by head trauma from ... might be inserted at the site of an aneurism ... vessel," said Jean Paul Allain, an associate professor of ...
Breaking Biology News(10 mins):Financial tool considered climate change uncertainty to select land for conservation 2Financial tool considered climate change uncertainty to select land for conservation 3G protein-coupled receptor mediates the action of castor oil 2G protein-coupled receptor mediates the action of castor oil 3Purdue professor to speak before Congress about nanotechnology in brain treatment research 2Purdue professor to speak before Congress about nanotechnology in brain treatment research 3Van Andel research institute study provides new details of fundamental cellular process 23429 1Internal Fixation Systems Announces 510 28k 29 Approval Granted by FDA for Subtalar Implants 23671 1Internal Fixation Systems Announces 510 28k 29 Approval Granted by FDA for Subtalar Implants 23671 2Parents May Hold Key to Treating Kids Obesity 88758 1Parents May Hold Key to Treating Kids Obesity 88758 2
... Fund (WWF) is alarmed by the dramatic decline of at ... Wildlife Reserve in Nepal, once a refuge that boasted among ... Himalayas. The recent survey of April 2008 showed a population ... , The Government of Nepal made a low-key announcement ...
... to produce a lot of a substance -- such as ... molecules that speed chemical reactions. Many jobs require highly specialized ... connect with certain molecules can be difficult. Natural catalysts, such ... food, get around this problem by shape-shifting to suit the ...
... With the goal of developing an accurate, powerful ... bone strength, scientists of the ETH Zurich Departments ... teamed up with supercomputing experts at IBM,s Zurich ... the team combines density measurements with a large-scale ...
Other Biology News:Tigers disappear from Himalayan refuge 2Synthetic molecules emulate enzyme behavior for the first time 2Synthetic molecules emulate enzyme behavior for the first time 3ETH Zurich and IBM improve diagnosis of osteoporosis 2
adult...
Porcine Serum Available Anticoagulants: N-02: Citrate N-04: Heparin (Na) N-06: K2EDTA N-08: Potassium Oxalate N-10: EDTA (Na) N-03: Alsevers N-05: ACD N-07: CPD N-09: K3EDTA N-11...
... Guinea Pig serum is collected from fasted Guinea ... Citrate N-04: Heparin (Na) ... N-10: EDTA (Na) N-03: ... CPD N-09: K3EDTA N-11: ...
EPH electrode, anode, 1. Category: Electrophoresis Systems & Standards & Reagents, IEF & SDS-PAGE & 2-D Electrophoresis, Multiphor II Kits & Components and Accessories....
Biology Products: